Cargando…
The Characterization of Disease Severity Associated IgG Subclasses Response in COVID-19 Patients
Increasing evidence suggests that dysregulated immune responses are associated with the clinical outcome of coronavirus disease 2019 (COVID-19). Nucleocapsid protein (NP)-, spike (S)-, receptor binding domain (RBD)- specific immunoglobulin (Ig) isotypes, IgG subclasses and neutralizing antibody (NAb...
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982848/ https://www.ncbi.nlm.nih.gov/pubmed/33763078 http://dx.doi.org/10.3389/fimmu.2021.632814 |
_version_ | 1783667807986122752 |
---|---|
author | Luo, Huanle Jia, Tingting Chen, Jiamin Zeng, Shike Qiu, Zengzhao Wu, Shu Li, Xu Lei, Yuxuan Wang, Xin Wu, Weihua Zhang, Renli Zou, Xuan Feng, Tiejian Ding, Ruxia Zhang, Yue Chen, Yao-Qing Sun, Caijun Wang, Tian Fang, Shisong Shu, Yuelong |
author_facet | Luo, Huanle Jia, Tingting Chen, Jiamin Zeng, Shike Qiu, Zengzhao Wu, Shu Li, Xu Lei, Yuxuan Wang, Xin Wu, Weihua Zhang, Renli Zou, Xuan Feng, Tiejian Ding, Ruxia Zhang, Yue Chen, Yao-Qing Sun, Caijun Wang, Tian Fang, Shisong Shu, Yuelong |
author_sort | Luo, Huanle |
collection | PubMed |
description | Increasing evidence suggests that dysregulated immune responses are associated with the clinical outcome of coronavirus disease 2019 (COVID-19). Nucleocapsid protein (NP)-, spike (S)-, receptor binding domain (RBD)- specific immunoglobulin (Ig) isotypes, IgG subclasses and neutralizing antibody (NAb) were analyzed in 123 serum from 63 hospitalized patients with severe, moderate, mild or asymptomatic COVID-19. Mild to modest correlations were found between disease severity and antigen specific IgG subclasses in serum, of which IgG1 and IgG3 were negatively associated with viral load in nasopharyngeal swab. Multiple cytokines were significantly related with antigen-specific Ig isotypes and IgG subclasses, and IL-1β was positively correlated with most antibodies. Furthermore, the old patients (≥ 60 years old) had higher levels of chemokines, increased NAb activities and SARS-CoV-2 specific IgG1, and IgG3 responses and compromised T cell responses compared to the young patients (≤ 18 years old), which are related with more severe cases. Higher IgG1 and IgG3 were found in COVID-19 patients with comorbidities while biological sex had no effect on IgG subclasses. Overall, we have identified diseases severity was related to higher antibodies, of which IgG subclasses had weakly negative correlation with viral load, and cytokines were significantly associated with antibody response. Further, advancing age and comorbidities had obvious effect on IgG1 and IgG3. |
format | Online Article Text |
id | pubmed-7982848 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-79828482021-03-23 The Characterization of Disease Severity Associated IgG Subclasses Response in COVID-19 Patients Luo, Huanle Jia, Tingting Chen, Jiamin Zeng, Shike Qiu, Zengzhao Wu, Shu Li, Xu Lei, Yuxuan Wang, Xin Wu, Weihua Zhang, Renli Zou, Xuan Feng, Tiejian Ding, Ruxia Zhang, Yue Chen, Yao-Qing Sun, Caijun Wang, Tian Fang, Shisong Shu, Yuelong Front Immunol Immunology Increasing evidence suggests that dysregulated immune responses are associated with the clinical outcome of coronavirus disease 2019 (COVID-19). Nucleocapsid protein (NP)-, spike (S)-, receptor binding domain (RBD)- specific immunoglobulin (Ig) isotypes, IgG subclasses and neutralizing antibody (NAb) were analyzed in 123 serum from 63 hospitalized patients with severe, moderate, mild or asymptomatic COVID-19. Mild to modest correlations were found between disease severity and antigen specific IgG subclasses in serum, of which IgG1 and IgG3 were negatively associated with viral load in nasopharyngeal swab. Multiple cytokines were significantly related with antigen-specific Ig isotypes and IgG subclasses, and IL-1β was positively correlated with most antibodies. Furthermore, the old patients (≥ 60 years old) had higher levels of chemokines, increased NAb activities and SARS-CoV-2 specific IgG1, and IgG3 responses and compromised T cell responses compared to the young patients (≤ 18 years old), which are related with more severe cases. Higher IgG1 and IgG3 were found in COVID-19 patients with comorbidities while biological sex had no effect on IgG subclasses. Overall, we have identified diseases severity was related to higher antibodies, of which IgG subclasses had weakly negative correlation with viral load, and cytokines were significantly associated with antibody response. Further, advancing age and comorbidities had obvious effect on IgG1 and IgG3. Frontiers Media S.A. 2021-03-04 /pmc/articles/PMC7982848/ /pubmed/33763078 http://dx.doi.org/10.3389/fimmu.2021.632814 Text en Copyright © 2021 Luo, Jia, Chen, Zeng, Qiu, Wu, Li, Lei, Wang, Wu, Zhang, Zou, Feng, Ding, Zhang, Chen, Sun, Wang, Fang and Shu. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Luo, Huanle Jia, Tingting Chen, Jiamin Zeng, Shike Qiu, Zengzhao Wu, Shu Li, Xu Lei, Yuxuan Wang, Xin Wu, Weihua Zhang, Renli Zou, Xuan Feng, Tiejian Ding, Ruxia Zhang, Yue Chen, Yao-Qing Sun, Caijun Wang, Tian Fang, Shisong Shu, Yuelong The Characterization of Disease Severity Associated IgG Subclasses Response in COVID-19 Patients |
title | The Characterization of Disease Severity Associated IgG Subclasses Response in COVID-19 Patients |
title_full | The Characterization of Disease Severity Associated IgG Subclasses Response in COVID-19 Patients |
title_fullStr | The Characterization of Disease Severity Associated IgG Subclasses Response in COVID-19 Patients |
title_full_unstemmed | The Characterization of Disease Severity Associated IgG Subclasses Response in COVID-19 Patients |
title_short | The Characterization of Disease Severity Associated IgG Subclasses Response in COVID-19 Patients |
title_sort | characterization of disease severity associated igg subclasses response in covid-19 patients |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982848/ https://www.ncbi.nlm.nih.gov/pubmed/33763078 http://dx.doi.org/10.3389/fimmu.2021.632814 |
work_keys_str_mv | AT luohuanle thecharacterizationofdiseaseseverityassociatediggsubclassesresponseincovid19patients AT jiatingting thecharacterizationofdiseaseseverityassociatediggsubclassesresponseincovid19patients AT chenjiamin thecharacterizationofdiseaseseverityassociatediggsubclassesresponseincovid19patients AT zengshike thecharacterizationofdiseaseseverityassociatediggsubclassesresponseincovid19patients AT qiuzengzhao thecharacterizationofdiseaseseverityassociatediggsubclassesresponseincovid19patients AT wushu thecharacterizationofdiseaseseverityassociatediggsubclassesresponseincovid19patients AT lixu thecharacterizationofdiseaseseverityassociatediggsubclassesresponseincovid19patients AT leiyuxuan thecharacterizationofdiseaseseverityassociatediggsubclassesresponseincovid19patients AT wangxin thecharacterizationofdiseaseseverityassociatediggsubclassesresponseincovid19patients AT wuweihua thecharacterizationofdiseaseseverityassociatediggsubclassesresponseincovid19patients AT zhangrenli thecharacterizationofdiseaseseverityassociatediggsubclassesresponseincovid19patients AT zouxuan thecharacterizationofdiseaseseverityassociatediggsubclassesresponseincovid19patients AT fengtiejian thecharacterizationofdiseaseseverityassociatediggsubclassesresponseincovid19patients AT dingruxia thecharacterizationofdiseaseseverityassociatediggsubclassesresponseincovid19patients AT zhangyue thecharacterizationofdiseaseseverityassociatediggsubclassesresponseincovid19patients AT chenyaoqing thecharacterizationofdiseaseseverityassociatediggsubclassesresponseincovid19patients AT suncaijun thecharacterizationofdiseaseseverityassociatediggsubclassesresponseincovid19patients AT wangtian thecharacterizationofdiseaseseverityassociatediggsubclassesresponseincovid19patients AT fangshisong thecharacterizationofdiseaseseverityassociatediggsubclassesresponseincovid19patients AT shuyuelong thecharacterizationofdiseaseseverityassociatediggsubclassesresponseincovid19patients AT luohuanle characterizationofdiseaseseverityassociatediggsubclassesresponseincovid19patients AT jiatingting characterizationofdiseaseseverityassociatediggsubclassesresponseincovid19patients AT chenjiamin characterizationofdiseaseseverityassociatediggsubclassesresponseincovid19patients AT zengshike characterizationofdiseaseseverityassociatediggsubclassesresponseincovid19patients AT qiuzengzhao characterizationofdiseaseseverityassociatediggsubclassesresponseincovid19patients AT wushu characterizationofdiseaseseverityassociatediggsubclassesresponseincovid19patients AT lixu characterizationofdiseaseseverityassociatediggsubclassesresponseincovid19patients AT leiyuxuan characterizationofdiseaseseverityassociatediggsubclassesresponseincovid19patients AT wangxin characterizationofdiseaseseverityassociatediggsubclassesresponseincovid19patients AT wuweihua characterizationofdiseaseseverityassociatediggsubclassesresponseincovid19patients AT zhangrenli characterizationofdiseaseseverityassociatediggsubclassesresponseincovid19patients AT zouxuan characterizationofdiseaseseverityassociatediggsubclassesresponseincovid19patients AT fengtiejian characterizationofdiseaseseverityassociatediggsubclassesresponseincovid19patients AT dingruxia characterizationofdiseaseseverityassociatediggsubclassesresponseincovid19patients AT zhangyue characterizationofdiseaseseverityassociatediggsubclassesresponseincovid19patients AT chenyaoqing characterizationofdiseaseseverityassociatediggsubclassesresponseincovid19patients AT suncaijun characterizationofdiseaseseverityassociatediggsubclassesresponseincovid19patients AT wangtian characterizationofdiseaseseverityassociatediggsubclassesresponseincovid19patients AT fangshisong characterizationofdiseaseseverityassociatediggsubclassesresponseincovid19patients AT shuyuelong characterizationofdiseaseseverityassociatediggsubclassesresponseincovid19patients |